Cas:137-19-9 4,6-dichlororesorcinol manufacturer & supplier

We serve Chemical Name:4,6-dichlororesorcinol CAS:137-19-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,6-dichlororesorcinol

Chemical Name:4,6-dichlororesorcinol
CAS.NO:137-19-9
Synonyms:MFCD00002274;4,6-Dichlorobenzene-1,3-diol;EINECS 205-284-1;4,6-Dichloro-1,3-dihydroxybenzene;4,6-Dichlororesorcinol
Molecular Formula:C6H4Cl2O2
Molecular Weight:179.00100
HS Code:2908199090

Physical and Chemical Properties:
Melting point:104-106 °C(lit.)
Boiling point:254 °C(lit.)
Density:1.624g/cm3
Index of Refraction:1.642
PSA:40.46000
Exact Mass:177.95900
LogP:2.40460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD00002274 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-Dichlororesorcinol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-Dichloro-1,3-dihydroxybenzene Use and application,MFCD00002274 technical grade,usp/ep/jp grade.


Related News: As far as chemical raw materials are concerned, China occupies a large share in the field of bulk raw materials and has become one of the world’s largest suppliers of chemical raw materials. 4,6-dichlororesorcinol manufacturer It was not clear which inquiry – the company’s or the government’s – was launched first and to what extent the subjects coincide. However, as Reuters reported last month, based on three sources familiar with the matter, the Justice Department’s investigation into Lilly includes a review of alleged manufacturing irregularities and records-tampering. 4,6-dichlororesorcinol supplier In a memo to Branchburg employees on May 20, Nellie Clark, head of the plant, summed up the outside lawyers’ findings: “In the end and very importantly, allegations that Lilly made false statements to the FDA were not substantiated.” 4,6-dichlororesorcinol vendor An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. 4,6-dichlororesorcinol factory An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant.